FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
本文は利用できません。元の情報源をご確認ください。
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.